Endocannabinoid System (ECS) Archives - Purablis-Medicinal Tinctures with CBD, THCA and THC

Endocannabinoid System (ECS) Marijuana Studies and

Endocannabinoid System (ECS) Cannabis Research

09/28/2018

Author(s): E. Appiah-Kusi1 , E. Leyden1 , S. Parmar1 , V. Mondelli2, P. McGuire1 and S. Bhattacharyya1.

A study that summarizes the current evidence regarding alterations in the endocannabinoid system and its relationship in disorders such as schizophrenia. View study

09/28/2018

Author(s): Antonio Luchicchi & Marco Pistis.

There is evidence suggesting that AEA and 2-AG possess specific pharmacological properties and that they also participate in different forms of synaptic plasticity and in different behavioral functions, such as learning and memory, reward and addiction, antinociception and anxiety. View study

09/28/2018

Author(s): Etienne Hebert-Chatelain 1,2, Leire Reguero 3, Nagore Puente 3, Beat Lutz 4 , Francis Chaouloff 1,2, Rodrigue Rossignol 2,5, Pier-Vincenzo Piazza 1,2 , Giovanni Benard 1,2, Pedro Grandes 3,6,Giovanni Marsicano 1,2,*,6.

There is convergent anatomical and biochemical evidence that functional CB1 receptors are found in the mitochondria of the brain at low levels. With these data it is possible to conclude that there may be a direct relationship between the CB1 receptor and the mitochondrial functions in the brain and can be detected if certain experimental procedures are applied. View study

09/28/2018

Author(s): Simona Pisanti, Cristina Borselli, Olimpia Oliviero, Chiara Laezza, Patrizia Gazzero, and Maurizio Bifulco.

Anandamide is potentially involved in the control of cancer growth directed both to the proliferation of tumor cells and to the angiogenic stimulation of the vasculature. View study